Medication info
Rivarozet 4/10 mg Tablets

Rivarozet 4/10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
White round film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP x 3)], 100 tablets/bottle
Approval status
Active

MFDS item code 202105579 · Approved 2021.07.28 · Insurance code 644914970

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg once daily. Adjust the dose as appropriate at intervals of 4 weeks or longer, according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram once daily is recommended for pitavastatin calcium in patients with hepatic impairment, initiation of treatment with this medicine (pitavastatin calcium/ezetimibe combination) is not recommended. The maximum dose is 2/10mg once daily. Use of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial, as well as mixed dyslipidemia. It helps to lower elevated total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels, while increasing HDL cholesterol which is the 'good' cholesterol. By using this drug in conjunction with a dietary regimen, blood lipid levels can be effectively controlled. This contributes to reducing the risk of cardiovascular disease and improving health. Therefore, this medication is used effectively in the treatment of dyslipidemia.

How to take

Adult dose

This medicine is administered once daily, regardless of food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg once daily. Adjust the dose as appropriate at intervals of 4 weeks or longer, according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram once daily is recommended for pitavastatin calcium in patients with hepatic impairment, initiation of treatment with this medicine (pitavastatin calcium/ezetimibe combination) is not recommended. The maximum dose is 2/10mg once daily. Use of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients with allergies to its components, those with severe liver disease, pregnant women, nursing mothers, or children. Patients with impaired liver function or those who consume alcohol excessively should use this medication with caution. Additionally, patients with kidney problems or a history of myopathy should be administered this drug carefully. If symptoms such as muscle pain or weakness appear while taking this medication, immediate consultation with a physician is necessary as these may indicate serious side effects such as muscle damage or rhabdomyolysis. Regular liver function tests should be conducted, and if liver enzyme levels are abnormally elevated, discontinuation of the medication may be required. This medication should not be administered to pregnant women or women of childbearing potential, and should be discontinued immediately if taken during pregnancy. Caution should be taken when this medication is combined with other drugs due to potential interactions, especially with cyclosporine, fibrate medications, and niacin. Elderly individuals may experience adverse reactions, so caution is needed when administering this medication to them. In the case of overdose, since there is no specific antidote, treatment should be symptomatic and monitoring of liver function and muscle status should be conducted. Finally, this medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

Constipation, abdominal pain, dyspepsia, nausea, upper respiratory infection, nasopharyngitis, headache, dizziness, abnormal liver enzymes, increased liver enzymes, pruritus, allergic pruritus, muscle spasms, prostatic dysplasia, myalgia, weakness, lethargy, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, urticaria, rash, erythema, angioedema, elevated bilirubin, increased cholinesterase, feeling of stiffness, drowsiness, insomnia, dry mouth, abdominal distension, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, thrombocytopenia, granulocytopenia, leukopenia, increased eosinophils, leukocytosis, elevated globulin, positive Coombs test, anemia, polyuria, elevated BUN, increased serum creatinine, decreased aldosterone, increased aldosterone, elevated adrenocorticotropic hormone, increased cortisol, decreased testosterone, muscle cramps, elevated myoglobin, increased CPK, skin tenderness, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste disturbance, discoloration of urine, hair loss, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, severe muscle weakness, ocular myasthenia, facial edema, arm edema, hyperreactivity, skin tingling, insomnia, loss of appetite, increased blood pressure, chest discomfort, weakness, dry mouth, nausea, chest pain, chest discomfort, systemic edema, tremors, upper abdominal pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, phlegm, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, hyperhidrosis, conjunctival hyperemia, renal failure, liver function abnormalities, increased blood creatinine, increased blood urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to maintain the drug’s efficacy by storing it at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)], 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.